-69.6%
MRNA vs DPZ
-34.0%
-35.6%
-95.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | DPZ | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.7% | -1.3% | +2.0% | +1.2% |
| 7D | -8.2% | -8.6% | +0.3% | -5.2% |
| 30D | +125.6% | -11.2% | +136.8% | +135.2% |
| 3M | +197.1% | +1.4% | +195.6% | +193.1% |
| 6M | +148.5% | -19.9% | +168.4% | +167.1% |
| YTD | +363.3% | -23.0% | +386.3% | +403.6% |
| 1Y | +462.0% | -28.2% | +490.2% | +526.9% |
| 3Y | +26.9% | -14.2% | +41.1% | +24.6% |
| 5Y | -69.6% | -33.4% | -36.2% | -66.0% |
| All | -69.6% | -34.0% | -35.6% | -66.0% |
Cumulative growth
Daily Returns
Daily percentage return beside DPZ.
Daily Out/Under-Performance
Portfolio return minus DPZ return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × DPZ return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded DPZ wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling